Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06150560 · ClinicalTrials.gov registry record · Phase 3
A Study of Angiotensin-II Receptor Blocker on Cardiovascular Remodeling (VALUE Trial)
A Phase 3 study of High Blood Pressure and Coarctation of Aorta, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT06150560: Recruiting Phase 3 study of High Blood Pressure and Coarctation of Aorta, sponsored by Mayo Clinic.
NCT06150560 is a Phase 3 study of High Blood Pressure and Coarctation of Aorta that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 120 participants, below the 499-participant average among 23 other High Blood Pressure trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06150560, a Phase 3 study of High Blood Pressure and Coarctation of Aorta, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the effectiveness and mechanism of action of Losartan in the treatment of coarctation of aorta.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Losartan
- DRUG Amlodipine
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2024-04-01 |
| Est. Completion | 2028-06-01 |
| Phase | Phase 3 |
What NCT06150560 shows while recruiting
NCT06150560 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 499-participant average among 23 other High Blood Pressure trials with a reported enrollment target (76% lower).
The record links to 2 conditions, with High Blood Pressure appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT06150560 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT06150560 about?
NCT06150560 is a clinical study titled "A Study of Angiotensin-II Receptor Blocker on Cardiovascular Remodeling (VALUE Trial)". The purpose of this study is to evaluate the effectiveness and mechanism of action of Losartan in the treatment of coarctation of aorta.
What is the current status of trial NCT06150560?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 120 participants. The study started on 2024-04-01. Estimated completion is 2028-06-01.
What conditions does trial NCT06150560 study?
This clinical trial studies the following conditions: High Blood Pressure, Coarctation of Aorta.
What interventions are being tested in trial NCT06150560?
The interventions under investigation include: Placebo (DRUG), Losartan (DRUG), Amlodipine (DRUG).
Who is sponsoring clinical trial NCT06150560?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06150560 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for High Blood Pressure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06150560's enrollment target sits among peer trials
120 13th of 23 higher than 11 of 23 other High Blood Pressure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other High Blood Pressure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Safest Choice of Antihypertensive Regimen for Postpartum Hypertension
RECRUITING · Phase 3
-
Addressing Hypertension Care in Africa Program
RECRUITING · NA
-
Blood Pressure Care for Advancing Real-World Evidence (BPCARE)
RECRUITING · NA
-
A Cardiometabolic Health Program Linked With Clinical-Community Support and Mobile Health Telemonitoring to Reduce Health Disparities
RECRUITING · NA
-
Addressing Cardiometabolic Health In Populations Through Early Prevention in the Great Lakes Region Project 1 - Epidemiology (ACHIEVE P1-EPI)
RECRUITING · NA
-
Polypill for Prevention of Cardiomyopathy
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI